Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 102065-89-4 | MDL No. : | MFCD09910173 |
Formula : | C3H10Cl2N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OOSDLMAZIRAMDN-UHFFFAOYSA-N |
M.W : | 145.03 | Pubchem ID : | 13491919 |
Synonyms : |
|
Num. heavy atoms : | 7 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 37.78 |
TPSA : | 38.05 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.97 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.3 |
Log Po/w (WLOGP) : | 0.14 |
Log Po/w (MLOGP) : | -0.16 |
Log Po/w (SILICOS-IT) : | 0.08 |
Consensus Log Po/w : | 0.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.93 |
Solubility : | 17.1 mg/ml ; 0.118 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.66 |
Solubility : | 31.6 mg/ml ; 0.218 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.03 |
Solubility : | 134.0 mg/ml ; 0.927 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 136293-86-2 ]
N-Methylazetidin-3-amine dihydrochloride
Similarity: 0.94
[ 124668-49-1 ]
N,N-Dimethylazetidin-3-amine dihydrochloride
Similarity: 0.83
[ 19777-67-4 ]
(R)-(+)-1,2-Diaminopropane dihydrochloride
Similarity: 0.73
[ 19777-66-3 ]
(S)-Propane-1,2-diamine dihydrochloride
Similarity: 0.73
[ 3187-76-6 ]
(trans)-Cyclopropane-1,2-diamine dihydrochloride
Similarity: 0.65
[ 136293-86-2 ]
N-Methylazetidin-3-amine dihydrochloride
Similarity: 0.94
[ 124668-49-1 ]
N,N-Dimethylazetidin-3-amine dihydrochloride
Similarity: 0.83
[ 162240-93-9 ]
(2R,6R)-2,6-Dimethylpiperazine dihydrochloride
Similarity: 0.74
[ 1152110-26-3 ]
(R)-1,3-Dimethylpiperazine dihydrochloride
Similarity: 0.67
[ 334618-23-4 ]
(R)-Piperidin-3-amine dihydrochloride
Similarity: 0.64
[ 136293-86-2 ]
N-Methylazetidin-3-amine dihydrochloride
Similarity: 0.94
[ 124668-49-1 ]
N,N-Dimethylazetidin-3-amine dihydrochloride
Similarity: 0.83
[ 935669-28-6 ]
3-Methylazetidine hydrochloride
Similarity: 0.61
[ 221095-80-3 ]
Azetidin-3-ylmethanamine dihydrochloride
Similarity: 0.58
[ 89381-03-3 ]
3,3-Dimethylazetidine hydrochloride
Similarity: 0.58